Cardiovascular
COHORT STUDY
Cardiovascular safety profile of GLP-1 receptor agonists in patients with metabolic syndrome: A real-world evidence stud...
This large-scale observational study analyzed cardiovascular outcomes in 45,678 patients with metabolic syndrome treated with GLP-1 receptor agonists...
CirculationIF: 37.8
GLP-1cardiovascular safetymetabolic syndromereal-world evidence